IL-12 Enhances Vaccine-Induced Immunity to Schistosomes by Augmenting Both Humoral and Cell-Mediated Immune Responses Against the Parasite

Journal of Immunology

Volumn 157, Issue 9, 1996, Pages 4068-4078

  Wynn, Thomas A ^a   Reynolds, Alicia ^b   James, Stephanie ^a   Cheever, Allen W ^a   Caspar, Pat ^a   Hieny, Sara ^a   Jankovic, Dragana ^a   Strand, Mette ^b   Sher, Alan ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HELMINTH ANTIBODY; INTERLEUKIN 12; NITRIC OXIDE;

ANIMAL; ANTIBODY PRODUCTION; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELLULAR IMMUNITY; CYTOTOXICITY; DRUG EFFECT; FEMALE; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; LARVA; LUNG; MACROPHAGE ACTIVATION; MOUSE; PARASITOLOGY; PATHOLOGY; SCHISTOSOMA MANSONI; SECRETION; TH2 CELL; VACCINATION;

ANIMALS; ANTIBODIES, HELMINTH; ANTIBODY FORMATION; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; IMMUNITY, CELLULAR; INTERLEUKIN-12; LARVA; LUNG; MACROPHAGE ACTIVATION; MICE; MICE, INBRED BALB C; NITRIC OXIDE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; TH2 CELLS; VACCINATION;

EID: 0030293445     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Mosmann, T. R., H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coffman. 1986. Two types of marine helper T cell clone: definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 126:2348.
2. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
3. + T cells to enhance priming for IFN-γ production and diminishes IL-4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 90:10188.
4. Swain, S. L., A. D. Weinberg, M. English, and G. Huston. 1990. IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145:3796.
5. Simpson, A. J. G., F. Hackett, T. Walker, R. DeRossi, and S. R. Smithers. 1985. Antibody response against schistosomulum surface antigens and protective immunity following immunization with highly irradiated cercariae of Schistosoma mansoni. Parasite Immunol. 7:133.
6. Dalton, J. P., T. D. Tom, and M. Strand. 1987. Cloning of a cDNA encoding a surface antigen of Schistosoma mansoni schistosomula recognized by sera of vaccinated mice. Proc. Natl. Acad. Sci. USA 84:4268.
7. Capron, M., and A. Capron. 1994. Immunoglobulin E and effector cells in schistosomiasis. Science 264:1876.
8. Sher, A., R. L. Coffman, S. Hieny, and A. W. Cheever. 1990. Ablation of eosinophil and IgE responses with anti-IL-5 or anti-IL-4 antibodies fails to affect immunity against Schistosoma mansoni in the mouse. J. Immunol. 145:3911.
9. Smythies, L. E., P. S. Coulson, and R. A. Wilson. 1992. Monoclonal antibody to IFN-γ modifies pulmonary inflammatory responses and abrogates immunity to Schistosoma mansoni in mice vaccinated with attenuated cercariae. J. Immunol. 149:3654.
10. James, S. L., and C. Nacy. 1993. Effector functions of activated macrophages against parasites. Curr. Opin. Immunol. 5:518.
11. Minard, P., D. A. Dean, R. Jacobson, W. Vannier, and K. D. Murrell. 1978. Immunization of mice with cobalt-60 irradiated Schistosoma mansoni cercariae. Am. J. Trop. Med. Hyg. 27:76.
12. + T cells in immunity to Schistosoma mansoni induced by 20 krad-irradiated and Ro 11-3128-terminated infections. Immunology 67:466.
13. Kelly, E., and D. G. Colley. 1988. In vivo effects of monoclonal anti-L3T4 antibody on immune responsiveness of mice infected with Schistosoma mansoni: reduction of irradiated cercariae-induced resistance. J. Immunol. 140:2737.
14. Piper, K. P., and D. J. McLaren. 1993. The role of T cells in vaccine immunity in the murine model of Schistosoma mansoni. Int. J. Parasitol. 23:245.
15. James, S. L., P. C. Natovitz, W. L. Farrar, and E. J. Leonard. 1984. Macrophages as effector cells of protective immunity in murine schistosomiasis: macrophage activation in mice vaccinated with radiation-attenuated cercariae. Infect. Immun. 44:569.
16. James, S. L., and J. A. Glaven. 1989. Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates. J. Immunol. 143:4208.
17. Oswald, I. P., T. A. Wynn, A. Sher, and S. L. James. 1994. NO as an effector molecule of parasite killing: modulation of its synthesis by cytokines. Comp. Biochem. Physiol. 108:11.
18. Wynn, T. A., I. P. Oswald, I. A. Eltoum, P. Caspar, C. J. Lowenstein, F. A. Lewis, S. L. James, and A. Sher. 1994. Elevated expression of Th1 cytokines and nitric oxide synthase in the lungs of vaccinated mice after challenge infection with Schistosoma mansoni. J. Immunol. 153:5200.
19. Caulada-Benedetti, Z., F. Al-Zamel, A. Sher, and S. James. 1991. Comparison of Th1- and Th2-associated immune reactivities stimulated by single versus multiple vaccination of mice with irradiated Schistosoma mansoni cercariae. J. Immunol. 146:1655.
20. Mangold, B. L., and D. A. Dean. 1986. Passive transfer with serum and IgG antibodies of irradiated cercariae-induced resistance against Schistosoma mansoni in mice. J. Immunol. 136:2644.
21. Wynn, T. A., D. Jankovic, S. Hieny, A. W. Cheever, and A. Sher. 1995. IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression, IgE production, and tissue eosinophilia. J. Immunol. 154:4701.
22. Chan, S. H., B. Perussia, J. W. Gupta, M. Kobayashi, M. Pospisil, H. A. Young, S. F. Wolf, D. Young, S. C. Clark, and G. Trinchieri. 1991. Induction of interferon γ production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173:869.
23. Scott, P. 1993. IL-12: initiation cytokine for cell-mediated immunity. Science 260:496.
24. Locksley, R. M. 1993. Interleukin 12 in host defense against microbial pathogens. Proc. Natl. Acad. Sci. USA 90:5879.
25. Heinzel, F. P., D. S. Schoenhaut, R. M. Rerko, L. E. Rosser, and M. K. Gately. 1993. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med 177:1505.
26. Sypek, J. P., C. L. Chung, S. E. H. Mayor, J. M. Subramanyam, S. J. Goldman, D. S. Sieburth, S. F. Wolf, and R. G. Schaub. 1993. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177:1797.
27. Afonso, L. C. C., T. M. Scharton, L. Q. Vieira, M. Wysocka, G. Trinchieri, and P. Scott. 1994. The adjuvant effect of interleukin 12 in a vaccine against Leishmania major. Science 263:235.
28. Miller, M. A., M. J. Skeen, and H. K. Ziegler. 1995. Nonviable bacterial antigens administered with IL-12 generate antigen-specific T cell responses and protective immunity against Listeria monocytogenes. J. Immunol. 155:4817.
29. Asheron, G. L., and S. H. Stone. 1965. Selective and specific inhibition of 24-hour skin reactions in the guinea pig. I. Immune deviation: description of the phenomenon and the effect of splenectomy. Immunology 9:205.
30. Parish, C. R. 1972. The relationship between humoral and cell-mediated immunity. Transplant. Rev. 13:35.
31. Janicki, B. W., G. P. Schechter, and K. E. Schultz. 1970. Cellular reactivity to tuberculin in immune and serologically unresponsive guinea pigs. J. Immunol. 105:527.
32. Boom, W. H., D. Liano, and A. K. Abbas. 1988. Heterogeneity of helper/inducer T lymphocytes. II. Effects of interleukin 4- and interleukin 2-producing T cell clones on resting B lymphocytes. J. Exp. Med. 167:1350.
33. Morris, S. C., K. D. Madden, J. J. Adamovicz, W. C. Gause, B. R. Hubbard, M. K. Gately, and F. D. Finkelman. 1994. Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J. Immunol. 152:1047.
34. James, S. L., R. Correa-Oliviera, and E. Leonard. 1984. Defective vaccine-induced immunity to Schistosoma mansoni in P strain mice. II. Analysis of cellular responses. J. Immunol. 133:1587.
35. Soisson, L. M., C. R. Masterson, T. D. Tom, M. T. McNally, G. H. Lowell, and M. Strand. 1992. Induction of protective immunity in mice using a 62-kDa recombinant fragment of Schistosoma mansoni surface antigen. J. Immunol. 149: 3612.
36. Litt, M. 1962. Studies in experimental eosinophilia. V. Eosinophils in lymph nodes of guinea pigs following primary antigenic stimulation. Am. J. Pathol. 42:529.
37. Wynn, T. A., I. Eltoum, A. W. Cheever, F. A. Lewis, W. C. Cause, and A. Sher. 1993. Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni. J. Immunol. 151:1430.
38. Svetic, A., F. D. Finkelman, Y. C. Jian, C. W. Dieffenback, D. E. Scott, K. F. McCarthy, A. D. Steinberg, and W. C. Gause. 1991. Cytokine gene expression after in vivo primary immunization with goal antibody to mouse IgD antibody. J. Immunol. 147:2391.
39. Wilson, R. A., P. S. Coulson, and B. Dixon. 1986. Migration of the schistosomula of Schistosoma mansoni in mice vaccinated with radiation-attenuated cercariae, and normal mice: an attempt to identify the timing and site of parasite death. Parasitology 92:101.
40. Dean, D. A., and B. L. Mangold. 1992. Evidence that both normal and immune elimination of Schistosoma mansoni take place at the lung stage of migration prior to parasite death. Am. J. Trop. Med. Hyg. 47:238.
41. Kassim, O. O., D. A. Dean, B. L. Mangold, and F. von Lichtenberg. 1992. Combined microautoradiographic and histopathologic analysis of the fate of challenge Schistosoma mansoni schistosomula in mice immunized with irradiated cercariae. Am. J. Trop. Med. Hyg. 47:231.
42. Pearce, E. J., and S. L. James. 1986. Post lung-stage schistosomula of Schistosoma mansoni exhibit transient susceptibility to macrophage-mediated cytotoxicity in vitro that may relate to late phase killing in vivo. Parasite Immunol. 8:513.
43. Bliss, J., V. Van Cleave, K. Murray, A. Wiencis, M. Ketchum, R. Maylor, T. Haire, C. Resmini, A. K. Abbas, and S. F. Wolf. 1996. IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response. J. Immunol. 156:887.
44. Gazzinelli, R. T., S. Hieny, T. A. Wynn, S. Wolf, and A. Sher. 1993. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon γ by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. USA 90:6115.
45. Hunter, C. A., E. Candolfi, C. Subauste, V. Van Cleave, and J. S. Remington. 1995. Studies on the role of interleukin-12 in acute murine toxoplasmosis. Immunology 84:16.
46. Wagner, R. D., H. Steinberg, J. F. Brown, and C. J. Czuprynski. 1994. Recombinant interleukin-12 enhances resistance of mice to Listeria monocytogenes infection. Microb. Pathog. 17:175.
47. Clemons, K. V., E. Brummer, and D. A. Stevens. 1995. Cytokine treatment of central nervous system infection: efficacy of interleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis. Antimicrob Agents Chemother. 38:460.
48. Sedegah, M., F. Finkelman, and S. L. Hoffman. 1994. Interleukin 12 induction of interferon gamma-dependent protection against malaria. Proc. Natl. Acad. Sci USA 91:10700.
49. Cooper, A. M., A. D. Roberts, E. R. Rhoades, J. E. Callahan, D. M. Getzy, and I. M. Orme. 1995. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology 84:423.
50. Zhou, P., M. C. Sieve, J. Bennett, K. J. Kwon-Chung, P. Tewari, R. T. Gazzinelli, A. Sher, and R. A. Seder. 1995. IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-γ. J. Immunol. 155:785.
51. Murray, H. W., and J. Hariprashad. 1995. Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis. J. Exp. Med. 181:387.
52. Wang, Z. E., S. Zheng, D. B. Corry, D. K. Dalton, R. Seder, S. L. Reiner, and R. M. Locksley. 1994. Interferon γ-independent effects of interleukin-12 administered during acute or established infection due to Leishmania major. Proc. Natl. Acad. Sci. USA 91:12932.
53. Wynn, T. A., A. W. Cheever, D. Jankovic, R. W. Poindexter, P. Caspar, F. A. Lewis, and A. Sher. 1995. An IL-12 based vaccination method for preventing fibrosis induced by schistosome infection. Nature 376:594.
54. Wynn, T. A., I. Eltoum, I. P. Oswald, A. W. Cheever, and A. Sher. 1994. Endogenous interleukin 12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J. Exp. Med. 179:1551.
55. Milich, D. R., S. F. Wolf, J. L. Hughes, and J. E. Jones. 1995. Interleukin 12 suppresses autoantibody production by reversing helper T-cell phenotype in hepatitis B e antigen transgenic mice. Proc. Natl. Acad. Sci USA 92:6847.
56. Mosmann, T. R., and K. W. Moore. 1991. The role of IL-10 in cross-regulation of Th1 and Th2 responses. In Immunoparasitology Today. C. Ash and R. B. Gallagher, eds. Elsevier Trends Journals, Cambridge, U.K., pp. A49-A53.
57. Soisson, L. A., G. D. F. Reid, I. O. Farah, M. Nyindo, and M. Strand. 1993. Protective immunity in baboons vaccinated with a recombinant antigen or radiation-attenuated cercariae of Schistosoma mansoni is antibody-dependent. J. Immunol. 151:4782.
58. Snapper, C. M., and W. E. Paul. 1987. Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236:944.
59. Finkelman, F. D., I. M. Katona, T. R. Mosmann, and R. L. Coffman. 1988. IFN-γ regulates the isotypes of Ig secreted during in vivo humoral immune responses. J. Immunol. 140:1022.
60. Finkelman, F. D., J. Holmes, I. M. Katona, J. F. J. Urban, M. P. Beckmann, L. S. Park, K. A. Schooley, R. L. Coffman, T. R. Mosmann, and W. E. Paul. 1996. Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8:303.
61. McKnight, A. J., G. J. Zimmer, I. Fogelman, S. F. Wold, and A. K. Abbas. 1994. Effects of IL-12 on helper T cell-dependent immune responses in vivo. J. Immunol. 152:2172.
62. Buchanan, J. M., L. A. Vogel, V. H. Van Cleave, and D. W. Metzger. 1995. Interleukin-12 alters the isotype-restricted antibody response of mice to hen egg-white lysozyme. Int. Immunol. 7:1519.
63. Germann, T., M. Bongartz, H. Dlugonska, E. Schmitt, L. Kolbe, E. Kolsch, F. J. Pdlaski, M. K. Gately, and E. Rude. 1995. IL-12 profoundly upregulates the synthesis of antigen-specific, complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo. Int. Immunol. 7:1649.
64. + T cells: IL-5 is essential for induction of antigen-specific antibody responses by Th2 but not Th1 clones. Eur. J. Immunol. 20:2219.
65. Wynn, T. A., D. Jankovic, S. Hieny, K. Zioncheck, P. Jardieu, A. W. Cheever, and A. Sher. 1995. IL-12 exacerbates rather than suppresses T helper 2-dependent pathology in the absence of endogenous IFN-γ. J. Immunol. 154:3999.
66. Snapper, C. M., F. D. Finkelman, and W. E. Paul. 1988. Differential regulation of IgG1 and IgE synthesis by interleukin 4. J. Exp. Med. 167:183.
67. 1/ IgE class switch program. Eur. J. Immunol. 22:1827.
68. Delgado, V., and D. J. McLaren. Evidence for enhancement of IgG1 subclass expression in mice polyvaccinated with radiation-attenuated cercariae of Schistosoma mansoni and the role of this isotype in serum-transferred immunity. 1990. Parasite Immunol. 12:15.
69. Bergquist, N. R., B. F. Hall, and S. James. 1994. Schistosomiasis vaccine development: translating basic research into practical results. Immunologist 2:131.
70. Pearce, E. J., S. L. James, S. Hieny, D. E. Lanar, and A. Sher. 1988. Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen. Proc. Natl. Acad. Sci. USA 85:5678.
71. Clerici, M., and G. Shearer. 1995. Cellular immunity and a type 1 cytokine profile in protection against HIV infection and progression to AIDS. Res. Immunol. 635.
72. Bouharoun-Tayoun, H., P. Attanath, A. Sabchareon, T. Chongsuphajaisiddhi, and P. Druilhe. 1990. Antibodies that protect humans against Plamodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J. Exp. Med. 172:1633.
73. + T cells and B cells are necessary for the transfer of protective immunity to Plasmodium chabaudi chabaudi. Eur. J. Immunol. 21:1433.